Antigenicity and immunogenicity of P30-derived peptides in experimental models of toxoplasmosis
- 31 December 1994
- journal article
- Published by Elsevier in Molecular Immunology
- Vol. 31 (17) , 1353-1363
- https://doi.org/10.1016/0161-5890(94)90054-x
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Comprehensive delineation of antigenic and immunogenic properties of peptides derived from the nef HIV-1 regulatory proteinVaccine, 1993
- Determination of B-cell epitopes of nef HIV-I protein: Immunogenicity related to their structureMolecular Immunology, 1992
- Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in sizeNature, 1992
- T helper cell epitopes of the human immunodeficiency virus (HIV-1) nef protein in rats and chimpanzeesMolecular Immunology, 1992
- Anchoring pockets in human histocompatibility complex leukocyte antigen (HLA) class I molecules: analysis of the conserved B ("45") pocket of HLA-B27.The Journal of Experimental Medicine, 1992
- Identification of a potent synthetic HIV1 immunogen compromising gag‐P24 tandem T‐ and B‐cell epitopesFEBS Letters, 1990
- IgA ANTIBODIES AGAINST P30 AS MARKERS OF CONGENITAL AND ACUTE TOXOPLASMOSISThe Lancet, 1988
- Preferential pairing of T-B specificities in the same antigen: the concept of directional helpVaccine, 1988
- Prediction of protein conformationBiochemistry, 1974
- Preparation and properties of an artificial antigen immunologically related to tobacco mosaic virusBiochimica et Biophysica Acta, 1963